Tiaprofenic acid
 |
|
| Systematic (IUPAC) name | |
|---|---|
|
(RS)-2-(5-benzoyl-2-thienyl)propanoic acid
|
|
| Clinical data | |
| AHFS/Drugs.com | Micromedex Detailed Consumer Information |
| Pregnancy category |
|
| Routes of administration |
oral |
| Legal status | |
| Legal status |
|
| Pharmacokinetic data | |
| Bioavailability | 90% |
| Metabolism | 10% hepatic |
| Biological half-life | 1.5-2.5h |
| Excretion | 50-80% urine |
| Identifiers | |
| CAS Number | 33005-95-7  |
| ATC code | M01AE11 (WHO) |
| PubChem | CID 5468 |
| DrugBank | DB01600 |
| ChemSpider | 5269 |
| UNII | 1LS1T6R34C |
| KEGG | D01325 |
| ChEBI | CHEBI:32221 |
| ChEMBL | CHEMBL365795 |
| Synonyms | 5-Benzoyl-α-methyl-2-thiopheneacetic acid |
| Chemical data | |
| Formula | C14H12O3S |
| Molar mass | 260.309 |
| Chirality | Racemic mixture |
| 3D model (Jmol) | Interactive image |
|
|
|
|
| (verify) | |
Tiaprofenic acid is a non-steroidal anti-inflammatory drug (NSAID) of the arylpropionic acid (profen) class, used to treat pain, especially arthritic pain. The typical adult dose is 300 mg twice daily. It is not recommended in children.
It is sparingly metabolised in the liver to two inactive metabolites. Most of the drug is eliminated unchanged in the urine. Renal disease impairs excretion, and it should be used with caution in renal disease.
Long-term use of tiaprofenic acid is associated with severe cystitis, roughly 100 times more commonly than other NSAIDs.[1] It is contraindicated in patients with cystitis and urinary tract infections.
The earliest reports of clinical use are from France in 1975 [2]
It is marketed under the trade names Surgam, Surgamyl and Tiaprofen, and in generic formulations. A sustained-release preparation is available. It is isomer with Suprofen.
References[edit]
- ^ Crawford MLA, Waller PC, Wood SM (1997). "Severe cystitis associated with tiaprofenic acid". British Journal of Urology. 79 (4): 578–584. doi:10.1046/j.1464-410X.1997.00094.x. PMID 9126086.
- ^ Pons J, Pasturel A (1975). "[How to improve postoperative complications in stomatological, maxillofacial and plastic surgery: evaluation of tiaprofenic acid]. [French]". Revue d Odonto-Stomatologie. 4 (6): 535–7.
External links[edit]
- Manufacturer Data Sheet [1]
 |
This drug article relating to the musculoskeletal system is a stub. You can help Wikipedia by expanding it. |
